Holen Sie sich die Stockscreener-App
12.44
0.16%
-0.0405
Schlusskurs vom Vortag:
$12.48
Offen:
$12.51
24-Stunden-Volumen:
47,541
Relative Volume:
6.61
Marktkapitalisierung:
$533.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$12.30
$13.00
1-Wochen-Bereich:
$9.02
$13.47
52-Wochen-Spanne:
$9.02
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
Jade Biosciences Inc
Sektor
Branche
Telefon
617-443-2400
Adresse
930 WINTER STREET, WALTHAM
Vergleichen Sie JBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
12.40 | 533.36M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
504.53 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.41 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.46 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.48 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
253.49 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-03-25 | Fortgesetzt | Jefferies | Buy |
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
Es liegen keine Finanzdaten für Jade Biosciences Inc (JBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Jade Biosciences Inc-Aktie (JBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dake Benjamin T | SEE REMARKS |
Aug 01 '24 |
Option Exercise |
1.74 |
1,507 |
2,622 |
14,252 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 17 '24 |
Buy |
1.67 |
928,110 |
1,549,944 |
7,893,678 |
| Eldridge George A | SEE REMARKS |
Jun 14 '24 |
Option Exercise |
2.14 |
15,000 |
32,100 |
20,022 |
| Eldridge George A | SEE REMARKS |
Jun 14 '24 |
Sale |
25.03 |
15,000 |
375,450 |
5,022 |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER |
Jun 14 '24 |
Option Exercise |
14.59 |
10,600 |
154,654 |
10,600 |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER |
Jun 14 '24 |
Sale |
25.00 |
10,600 |
265,000 |
0 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
Jun 13 '24 |
Option Exercise |
2.14 |
6,000 |
12,840 |
11,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
Jun 13 '24 |
Sale |
24.50 |
6,000 |
147,000 |
5,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
May 17 '24 |
Option Exercise |
2.14 |
4,000 |
8,560 |
9,602 |
| Gillies Hunter | CHIEF MEDICAL OFFICER |
May 17 '24 |
Sale |
21.08 |
4,000 |
84,332 |
5,602 |
0.39%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):